Nisa Investment Advisors’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,653
| Closed | -$263K | – | 3111 |
|
|
2025
Q4 | $263K | Sell |
3,653
-226
| -6% | -$14.6K | ﹤0.01% | 1163 |
|
|
2025
Q3 | $169K | Buy |
3,879
+47
| +1% | +$1.9K | ﹤0.01% | 1286 |
|
|
2025
Q2 | $109K | Buy |
3,832
+162
| +4% | +$4.83K | ﹤0.01% | 1367 |
|
|
2025
Q1 | $108K | Buy |
3,670
+239
| +7% | +$7.44K | ﹤0.01% | 1381 |
|
|
2024
Q4 | $99.8K | Sell |
3,431
-34
| -1% | -$1.42K | ﹤0.01% | 1472 |
|
|
2024
Q3 | $159K | Sell |
3,465
-934
| -21% | -$40.5K | ﹤0.01% | 1332 |
|
|
2024
Q2 | $180K | Buy |
4,399
+1,076
| +32% | +$30.9K | ﹤0.01% | 1334 |
|
|
2024
Q1 | $84.8K | Buy |
3,323
+123
| +4% | +$1.93K | ﹤0.01% | 1516 |
|
|
2023
Q4 | $29K | Buy |
3,200
+3,180
| +15,900% | +$21.3K | ﹤0.01% | 1765 |
|
|
2023
Q3 | $128 | Sell |
20
-1,878
| -99% | -$16.2K | ﹤0.01% | 2711 |
|
|
2023
Q2 | $21K | Buy |
1,898
+964
| +103% | +$12.1K | ﹤0.01% | 2082 |
|
|
2023
Q1 | $14K | Buy |
934
+910
| +3,792% | +$20K | ﹤0.01% | 2100 |
|
|
2022
Q4 | $1K | Sell |
24
-26
| -52% | -$388 | ﹤0.01% | 2496 |
|
|
2022
Q3 | $1K | Sell |
50
-188
| -79% | -$3.6K | ﹤0.01% | 2495 |
|
|
2022
Q2 | $3K | Hold |
238
| – | – | ﹤0.01% | 2328 |
|
|
2022
Q1 | $4K | Sell |
238
-1,920
| -89% | -$32.6K | ﹤0.01% | 2324 |
|
|
2021
Q4 | $36K | Buy |
2,158
+1,591
| +281% | +$38K | ﹤0.01% | 1810 |
|
|
2021
Q3 | $14 | Sell |
567
-4,600
| -89% | -$100K | ﹤0.01% | 2160 |
|
|
2021
Q2 | $128 | Hold |
5,167
| – | – | ﹤0.01% | 1578 |
|
|
2021
Q1 | $113 | Hold |
5,167
| – | – | ﹤0.01% | 1702 |
|
|
2020
Q4 | $132K | Buy |
+5,167
| New | +$151K | ﹤0.01% | 1623 |
|
Other funds holding RNAM
Nisa Investment Advisors's RNAM Position: Q1 2026 in Review
Nisa Investment Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,653 shares — an estimated $263K sold.
Nisa Investment Advisors first reported a position in RNAM in Q4 2020 and held it in 21 quarters. The position peaked at $263K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Nisa Investment Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Nisa Investment Advisors sold 3,653 Avidity Biosciences shares in Q1 2026, an estimated $263K.
- Nisa Investment Advisors first reported a position in Avidity Biosciences in Q4 2020 and held it in 21 quarters.
- Nisa Investment Advisors's Avidity Biosciences position peaked at $263K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.